GlaxoSmithKline (GSK) has firmly acquired the number one position in the Egyptian pharmaceutical market ... are driving the bulk of the growth of the company today. GSK maintains a relatively ...

GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals. The company's product portfolio includes prescription medicines and ...

GSK GSK-0.10%decrease; red down pointing triangle shares topped the Stoxx Europe 600 index on Thursday after the pharmaceutical company agreed to pay up to $2.2 billion to settle thousands of U.S ...

GlaxoSmithKline Pharma, celebrating 100 years in India ... Additionally, the Rs 3,500 crore company will widen its preventive portfolio by introducing more adult vaccines, shifting the focus ...

GlaxoSmithKline or GSK, is one of the most renowned pharma giants around the globe. In a recent development regarding the UK-based company with presence around the globe, including India ...

GlaxoSmithKline Pharmaceuticals Limited is an India-based global healthcare company. The Company is engaged in the business of manufacturing, distributing and trading in pharmaceuticals.

During Lacalle's meeting with British Prime Minister Boris Johnson, the launch of a sovereign bond linked to sustainability goals was discussed Pharmaceutical ... GSK has now set a date. The ...

The agreement will see the pharmaceutical company make a maximum aggregate payment of $2.2 billion to resolve all of those cases. GSK added that other terms of the settlement were confidential.

View upcoming earnings forecasts and in-depth analysis of company forecasts.

With Gilead Sciences sprinting to a likely approval next year for its long-acting pre-exposure prophylaxis (PrEP) drug for HIV, the California company has a chance to one-up GSK. While the British ...

No Data For Bulk Deal. *Involves transaction of at least 0.5% of the listed shares of a company. What was Glaxosmithkline Pharmaceuticals Ltd share price previously? Glaxosmithkline ...